Acturis Canada has secured a key endorsement from the Center for Study of Insurance Operations (CSIO), achieving API Security ...

Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

The consequences of President Trump's actions on drug pricing continue to play out, with Bristol Myers Squibb insisting it will charge the same in the UK for new schizophrenia drug Cobenfy as in the ...

Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and ...

CSIO congratulates Acturis Canada Inc. (Acturis) on achieving CSIO’s API Security Standards Certification for their Acturis ...

In addition to schedule changes reported on our closings page, other schedule changes have been reported for January 30, 2026. 2 people found dead following house fire in Hawkins County Two people ...

TheNewswire - January 29, 2026 / TheNewswire / - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB:BVAXF) (“BioVaxys" or the "Company"), a clinical stage biotechnology company focused on ...

Alternative battery technologies, hybrid energy storage, and the use of AI-based solutions drive advances in battery energy ...

If you are looking for new job in 2026, take a look at some of the most exciting organisations looking to recruit.

Discover why Electrical Engineering is known as the 'Masters of Microchip' in 2026. Explore career scopes in VLSI, EV tech, and semiconductors, including salary insights for top-tier engineering roles ...

Industry partners have welcomed the consolidation. Orange, which operates one of Europe’s largest public LoRaWAN networks using Actility’s ThingPark platform, described the acquisition as positive for ...

Europe’s regulatory direction adds pressure for professionalized lifecycle management. The EU’s Cyber Resilience Act (CRA) is intended to require digital products to be designed, updated, and ...